Summary
Boston Scientific Corporation (BSX) filed an 8-K report on May 15, 2019, detailing key corporate governance changes and executive appointments. The company announced the appointment of Jonathan Monson as Vice President, Global Controller and Chief Accounting Officer, effective July 1, 2019, bringing extensive experience within the company's finance and accounting divisions. Furthermore, the report highlights significant amendments to the company's By-Laws, approved by stockholders at the May 9, 2019 Annual Meeting. These amendments include the adoption of a majority vote standard for uncontested director elections and the implementation of proxy access by-laws, allowing certain long-term stockholders to nominate directors. These changes aim to enhance corporate governance and shareholder engagement.
Key Highlights
- 1Jonathan Monson appointed as Vice President, Global Controller and Chief Accounting Officer, effective July 1, 2019.
- 2Stockholders approved amendments to the By-Laws adopting a majority vote standard in uncontested director elections.
- 3A new director resignation policy is now in effect, requiring resignation tenders from directors failing to receive a majority vote in uncontested elections.
- 4Proxy access by-laws were adopted, allowing eligible long-term stockholders to nominate directors for inclusion in company proxy materials starting in 2020.
- 5All ten incumbent director nominees were elected to the Board of Directors.
- 6The advisory vote on executive compensation was approved.
- 7Ernst & Young LLP was ratified as the company's independent registered public accounting firm for the 2019 fiscal year.